UNSPSC 51172464: Choline/dexpanthenol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA900. This VA Drug Class (GA900) classifies this compound as belonging to the group GASTRIC MEDICATIONS, OTHER.

UNSPSC 51172464 Choline/dexpanthenol is a Commodity code that represents pharmaceutical active ingredients and additives used in formulations for nutritional supplementation, energy metabolism support, and pharmaceutical manufacturing. Recent state and local opportunities under this code show little direct procurement activity for the ingredient itself; instead, issuing bodies are soliciting finished pharmaceutical products, generic multi-source drugs, and over-the-counter items that may contain choline or dexpanthenol as components within broader formulations. The primary issuing bodies in recent activity are state health agencies, cooperative purchasing alliances, and county criminal-justice departments. The Texas Health and Human Services Commission and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent state-level pharmaceutical procurement vehicles, while Collin County Community Supervision and Corrections Department represents county-level demand for drug-testing services and related pharmaceutical support.

Recent opportunities span Texas, Minnesota, and Oregon through MMCAP's multistate cooperative purchasing structure. The Minnesota MMCAP RFP for generic multi-source pharmaceuticals and OTC products (solicitation S1070000015802, due March 26, 2026) sought manufacturers to supply comprehensive generic drugs and over-the-counter items through authorized wholesalers, with evaluation weighted heavily on price competitiveness (75 percent) and compliance with Good Manufacturing Practices and Drug Supply Chain Security Act requirements. The Texas HHS Commission issued a Request for Information (RFI HHS0017013, posted April 3, 2026) exploring direct-to-manufacturer prescription programs to improve cost management and fulfillment efficiency outside traditional pharmacy benefit manager arrangements. Collin County's RFP 2026-327 for offender specimen collection and drug testing services (due July 23, 2026, estimated value $600,000) required vendors to perform immunoassay screening with LC/MS/MS or GC/MS confirmation and maintain SAMHSA, Texas DPS, or CAP lab certification. State and local governments buying under this code primarily pursue finished pharmaceutical products and services rather than raw active ingredients, with emphasis on cost, compliance with regulatory standards, and multi-jurisdictional distribution through established wholesaler networks.